These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


92 related items for PubMed ID: 14523106

  • 1. Application of a bacterial two-hybrid system for the analysis of protein-protein interactions between FemABX family proteins.
    Rohrer S, Berger-Bächi B.
    Microbiology (Reading); 2003 Oct; 149(Pt 10):2733-2738. PubMed ID: 14523106
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. X-ray crystal structure of Staphylococcus aureus FemA.
    Benson TE, Prince DB, Mutchler VT, Curry KA, Ho AM, Sarver RW, Hagadorn JC, Choi GH, Garlick RL.
    Structure; 2002 Aug; 10(8):1107-15. PubMed ID: 12176388
    [Abstract] [Full Text] [Related]

  • 4. Lif, the lysostaphin immunity factor, complements FemB in staphylococcal peptidoglycan interpeptide bridge formation.
    Tschierske M, Ehlert K, Strandén AM, Berger-Bächi B.
    FEMS Microbiol Lett; 1997 Aug 15; 153(2):261-4. PubMed ID: 9271851
    [Abstract] [Full Text] [Related]

  • 5. In vitro assembly of a complete, pentaglycine interpeptide bridge containing cell wall precursor (lipid II-Gly5) of Staphylococcus aureus.
    Schneider T, Senn MM, Berger-Bächi B, Tossi A, Sahl HG, Wiedemann I.
    Mol Microbiol; 2004 Jul 15; 53(2):675-85. PubMed ID: 15228543
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The essential Staphylococcus aureus gene fmhB is involved in the first step of peptidoglycan pentaglycine interpeptide formation.
    Rohrer S, Ehlert K, Tschierske M, Labischinski H, Berger-Bächi B.
    Proc Natl Acad Sci U S A; 1999 Aug 03; 96(16):9351-6. PubMed ID: 10430946
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Cell wall monoglycine cross-bridges and methicillin hypersusceptibility in a femAB null mutant of methicillin-resistant Staphylococcus aureus.
    Strandén AM, Ehlert K, Labischinski H, Berger-Bächi B.
    J Bacteriol; 1997 Jan 03; 179(1):9-16. PubMed ID: 8981974
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Screening and Toxicity Analysis of Catechin Isomers Against FemA Protein.
    Singhal D, Saxena S.
    Indian J Pharm Sci; 2015 Jan 03; 77(6):758-63. PubMed ID: 26997705
    [Abstract] [Full Text] [Related]

  • 18. Studies on prolysostaphin processing and characterization of the lysostaphin immunity factor (Lif) of Staphylococcus simulans biovar staphylolyticus.
    Thumm G, Götz F.
    Mol Microbiol; 1997 Mar 03; 23(6):1251-65. PubMed ID: 9106216
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of methicillin resistance by cefoxitin disk diffusion and PBP2a latex agglutination test in mecA-positive Staphylococcus aureus, and comparison of mecA with femA, femB, femX positivities.
    Akcam FZ, Tinaz GB, Kaya O, Tigli A, Ture E, Hosoglu S.
    Microbiol Res; 2009 Mar 03; 164(4):400-3. PubMed ID: 17481872
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.